Related Experiment Video
Updated: May 26, 2026
09:57
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
Educational session: managing chronic myeloid leukemia as a chronic disease
1Jena University Hospital, Jena, Germany.
Hematology. American Society of Hematology. Education Program
|December 14, 2011
Summary
Chronic myeloid leukemia (CML) is now manageable with tyrosine kinase inhibitors (TKIs), offering a good prognosis. However, challenges remain in managing CML, including side effects, adherence, and specific patient populations.
Area of Science:
- Hematology
- Oncology
- Pharmacology
Background:
- Chronic myeloid leukemia (CML) has transitioned from a fatal diagnosis to a manageable condition with a favorable prognosis due to targeted therapies.
- Tyrosine kinase inhibitors (TKIs) have revolutionized CML treatment, significantly improving patient survival rates.
- Despite advances, CML management presents ongoing challenges, including disease progression to blast crisis and increasing patient prevalence.
Purpose of the Study:
- To review the current landscape of chronic myeloid leukemia (CML) management.
- To highlight the long-term challenges associated with CML treatment and surveillance.
- To discuss strategies for optimizing patient care and outcomes in CML.
Main Methods:
- Review of current literature on CML pathogenesis and treatment.
- Analysis of the impact of tyrosine kinase inhibitors (TKIs) on CML prognosis.
- Discussion of management strategies for diverse patient populations and treatment adherence.
Main Results:
- CML treatment with TKIs has led to a median survival exceeding 20 years, transforming the disease's outlook.
- A small percentage of patients still experience blast crisis, with limited therapeutic options and poor survival.
- Increasing CML prevalence necessitates optimized management, including access to modern therapies and standardized surveillance.
Conclusions:
- Optimal CML management requires continuous treatment, adherence, and comprehensive patient information.
- Standardized surveillance methods and addressing challenges in specific age groups (children, young adults, elderly) are crucial.
- Managing TKI side effects and ensuring long-term adherence are key to sustained therapeutic success in chronic myeloid leukemia.
More Related Videos
Related Concept Videos
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:18Chronic Kidney Disease IV: Nursing Management
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...